1
de Jong, Marit, Oskam, Marieke J., Sep, Simone J. S., Ozcan, Behiye, Rutters, Femke, Sijbrands, Eric J. G., Elders, Petra J. M., Siegelaar, Sarah E., Devries, J. Hans, Tack, Cees J., Schroijen, Marielle, de Valk, Harold W., Abbink, Evertine J., Stehouwer, Coen D. A., Jazet, Ingrid, Wolffenbuttel, Bruce H. R., Peters, Sanne A. E., Schram, Miranda T.
Veröffentlicht in: de Jong , M , Oskam , M J , Sep , S J S , Ozcan , B , Rutters , F , Sijbrands , E J G , Elders , P J M , Siegelaar , S E , Devries , J H , Tack , C J , Schroijen , M , de Valk , H W , Abbink , E J , Stehouwer , C D A , Jazet , I , Wolffenbuttel , B H R , Peters , S A E & Schram , M T 2020 , ' Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: Findings from the Dutch Diabetes Pearl cohort ' , BMJ Open Diabetes Research and Care , vol. 8 , no. 1 , e001365 . https://doi.org/10.1136/bmjdrc-2020-001365;
2020
2
de Jong, Marit, Oskam, Marieke J., Sep, Simone J. S., Ozcan, Behiye, Rutters, Femke, Sijbrands, Eric J. G., Elders, Petra J. M., Siegelaar, Sarah E., DeVries, J. Hans, Tack, Cees J., Schroijen, Marielle, de Valk, Harold W., Abbink, Evertine J., Stehouwer, Coen D. A., Jazet, Ingrid, Wolffenbuttel, Bruce H. R., Peters, Sanne A. E., Schram, Miranda T.
Veröffentlicht in: de Jong , M , Oskam , M J , Sep , S J S , Ozcan , B , Rutters , F , Sijbrands , E J G , Elders , P J M , Siegelaar , S E , DeVries , J H , Tack , C J , Schroijen , M , de Valk , H W , Abbink , E J , Stehouwer , C D A , Jazet , I , Wolffenbuttel , B H R , Peters , S A E , Schram , M T & Diabet Pearl Parelsnoer Initiative 2020 , ' Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes : findings from the Dutch Diabetes Pearl cohort ' , BMJ Open Diabetes Research & Care , vol. 8 , no. 1 , 001365 . https://doi.org/10.1136/bmjdrc-2020-001365;
2020
4
van Oort, S., Rutters, F., Warle-van Herwaarden, M. F., Schram, M. T., Stehouwer, C. D., Tack, C. J., Abbink, E. J., Wolffenbuttel, B. H., van der Klauw, M. M., DeVries, J. H., Siegelaar, S. E., Sijbrands, E. J., Ozcan, B., de Valk, H. W., Silvius, B., Schroijen, M. A., Jazet, I. M., van Ballegooijen, A. J., Beulens, J. W. J., Elders, P. J., Kramers, C.
Veröffentlicht in: van Oort , S , Rutters , F , Warle-van Herwaarden , M F , Schram , M T , Stehouwer , C D , Tack , C J , Abbink , E J , Wolffenbuttel , B H , van der Klauw , M M , DeVries , J H , Siegelaar , S E , Sijbrands , E J , Ozcan , B , de Valk , H W , Silvius , B , Schroijen , M A , Jazet , I M , van Ballegooijen , A J , Beulens , J W J , Elders , P J & Kramers , C 2021 , ' Characteristics associated with polypharmacy in people with type 2 diabetes : the Dutch Diabetes Pearl cohort ' , Diabetic Medicine , vol. 38 , no. 4 , 14406 . https://doi.org/10.1111/dme.14406;
2021